Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

health and fitness

Allergy Standards Announces the Appointment of Emma Coonan as Executive Assistant to CEO

Leave a comment


“Emma’s qualifications, training, and experience working with CEO’s at the highest level in addition to her work in the health and wellbeing field are a perfect combination for a scaling life sciences and digital health company, making a digital footprint on an international scale.”


DUBLIN (PRWEB)

Allergy Standards Limited (ASL) announced today the appointment of Emma Coonan as Executive Assistant to CEO.

Emma is responsible for supporting the efficient and effective management of day-to-day and strategic operations in the CEO’s office and across the business. Working closely with the CEO and the wider Allergy Standards team, Emma’s role includes process management, operational planning, and project management.

Emma has over twelve years’ experience in Executive Support, Senior Administration, and Event Management roles within corporate, academic, and not-for-profit sectors including Trinity Foundation, Trinity College Dublin; The Royal College of Physicians of Ireland; NCB Stockbrokers Ltd; Deloitte & Touche, and Chill insurance Ltd. Emma is an accredited Psychotherapist and has combined her work in the corporate arena with her private Psychotherapy practice for a number of years.

Emma graduated from National University of Ireland, Maynooth, with a BA (Hons) in Media Studies and English. Ongoing professional and personal development is a passion of Emma’s, and since graduating Emma has been awarded a HDip (Hons) in Counselling and Psychotherapy, an MA (Hons) in Psychotherapy, a Diploma in Event Management, and is a certified trainer in Training Delivery and Evaluation. Emma has enjoyed volunteer experience as a reviewer of children’s books for an award winning children’s literature platform and as a local community club leader in one of Ireland’s leading youth organisations.

“Emma’s qualifications, training, and experience working with CEO’s at the highest level in addition to her work in the health and wellbeing field are a perfect combination for a scaling life sciences and digital health company, making a digital footprint on an international scale,” said Dr. John McKeon, CEO.

Emma can be found hiking and walking at every opportunity, when she’s not searching for her next great read amongst the bookshops and stalls of Dublin.

“I am delighted to join the Allergy Standards team, and to be part of a company which is a leader in healthy lifestyles, excellence, and innovation. I am looking forward to working with John and the team to build towards the future,” said Emma Coonan.

About Allergy Standards

Allergy Standards Limited (ASL) mantra is design thinking and an innovation for healthier indoor air for the allergy aware consumer. As an independent, international certification company, it creates meaningful scientific standards for testing a wide range of products and services to determine their impact on improving indoor air quality. ASL’s intellectual property portfolio includes unique testing protocols and suitability specifications for products to be CERTIFIED asthma & allergy friendly®. ASL’s mission is to improve lives by empowering people create the healthiest possible indoor environment through science, education and innovation. Our vision is a world where all ER visits caused by exposure to avoidable indoor allergens are eliminated.

Share article on social media or email:

Industry: Healthcare

Sun Life Selects TreatGxplus as a Pharmacogenomic Solution for Employee Wellness

Leave a comment


TreatGx supports the development of personalized treatment plans and prescribed medication options. It is a remarkable solution that is changing how we can help patients recover more quickly.


VANCOUVER, British Columbia (PRWEB)

GenXys Health Care Systems is proud to share that Sun Life selected TreatGxplus as part of its disability management toolkit for plan sponsors. According to Sun Life, the goal is to help plan members get back to work faster and live healthier lives. The award-winning TreatGxplus solution, an advanced precision prescribing software including a pharmacogenetic test, is offered by LifeLabs, Canada’s largest diagnostic and laboratory company, in partnership with GenXys.

TreatGx, the precision prescribing application, presents over 40,000 prescription options and models out 250,000 drug interactions through its comprehensive and interactive online medication decision support engine. The cloud-based platform is accessible to patients and their healthcare providers across Canada and the United States.

“Identifying safe and effective medication options for the patient is the goal,” said Dr. Martin Dawes, a Professor of Family Medicine, Chief Scientific Officer of GenXys.”TreatGx helps us achieve that goal by supporting the development of personalized treatment plans and prescribed medication options. It is a remarkable solution that is changing how we can help patients recover more quickly.”

The adoption of pharmacogenetic solutions by leading insurance companies such as Sun Life and UnitedHealth Group reaffirms the growing role of genetics in primary care and across health systems. With the level of clinical utility and relevance provided by TreatGx, pharmacogenetics can now enable medication decision support at the point of care.

While the initial Sun Life deployment will focus on mental health and chronic pain, TreatGx covers 35+ conditions where there are high levels of pharmacogenetic evidence. Echoing the recent statement by the Association for Molecular Pathology, every health-related pharmacogenetic link in TreatGx is supported by the best clinical evidence. For clinical accuracy and relevance, the solution also includes other variables such as other conditions, concurrent medications, and biophysical data in its proprietary algorithms that set it apart from others.

Building on significant growth in Canada, GenXys is establishing its footprint in the US through strong strategic partnerships. It is also working with stakeholders from healthcare systems and labs to incorporate clinically relevant pharmacogenetics at the point of care for ‘nextgen’ prescribing.

“We are delighted that the inclusion of pharmacogenetics in primary care is becoming a reality on a mass scale. It is the most applicable and actionable use of genetics for increasing patient safety, improving population health, and reducing the cost of healthcare,” said Karl Pringle, CEO of GenXys.

About GenXys Health Care Systems Inc.

GenXys offers best-in-class precision prescribing solutions to solve healthcare’s most pressing challenges. Our precision prescribing software and pharmacogenetic solutions can prevent adverse drug reactions, a leading cause of death, and personalized drug selection to increase drug efficacy. Powering every prescription globally with our software improves patient safety, population health, and reduces healthcare costs.

For more information, please visit http://www.genxys.com.

Media Contact:

Jenny Lu

T: 206-408-3099

E: info(at)genxys(dot)com

LinkedIn: https://www.linkedin.com/company/genxys-health-care-systems/

Share article on social media or email:

Health

Hemanext Announces Publication of Data Demonstrating Significant Benefits Following the Transfusion of Hypoxically Stored Red Blood Cells

Leave a comment


When we look at all of the data from our study, it appears that storing RBCs hypoxically could result in better transfusion patient outcomes. Pedro Cabrales, PhD, University of California, San Diego


LEXINGTON, Mass. (PRWEB)

Hemanext, a privately held medical technology company dedicated to improving the quality, safety, efficacy and cost of transfusion therapy, today announced the publication of clinically significant data in Shock, the official journal of the Shock Society.

According to data generated in animal studies, “Resuscitation from hemorrhagic shock via transfusion of hypoxically stored red blood cells (RBCs, which carry oxygen throughout the body and transport carbon dioxide to the lungs for exhalation), recovered cardiac function, restored hemodynamic stability and improved outcomes” when compared to conventionally stored blood.

The study authors explained that trauma accounts for ten percent of deaths worldwide and is the third most-common cause of death in the United States. Hemorrhagic shock due to the rapid and extreme loss of blood is responsible for approximately fifty percent of trauma deaths. Developing improved methods for treating hemorrhagic shock is a high priority for trauma physicians around the world.

“Conventional RBCs have long been the standard of care in trauma. However, oxidative damage occurs that could impact patient outcome. These new data by Williams et. al shows that hypoxically stored RBCs achieve multiple clinically important functional resuscitation goals with a significantly smaller volume and meeting the FDA benchmark of 24-hour RBC recovery,” said Tor Hervig, MD, PhD; founding member of the Traumatic Hemostasis and Oxygenation Research (THOR) Network; Chief Medical Officer, Blood bank, Haugesund Hospital: Senior Consultant, Haukeland University Hospital.

The oxidative structural and functional damage known as “storage lesions” can limit the effectiveness of RBCs when transfused into patients. In many cases, the damaged RBCs may lead to poor clinical outcomes for highly vulnerable patients, including people suffering from shock or who require repeated transfusions to treat conditions such as sickle cell anemia, thalassemia and myelodyplastic syndrome.

Researchers are exploring the benefits of storing RBCs in oxygen-starved containers to prevent oxidative damage to the cells due to the presence of oxygen. In this study, the authors observed the following significant differences in outcomes between hypoxically and conventionally stored red blood cells:

  • Approximately fifty percent less RBC volumes were required to resuscitate animals from hemorrhagic shock when transfusing hypoxically stored RBCs – the authors cited this as the principal finding of the study

  • Faster reduction of blood lactate levels in transfused animals with the hypoxically stored RBCs compared to levels detected in the conventionally stored RBCs – reduced lactate is a biomarker for increased oxygen delivery by the RBCs, which is particularly important for shock patients

  • Hypoxically stored RBCs produced a significantly smaller degree of organ and tissue damage compared to conventionally stored RBC to arrive at the same clinically relevant hemodynamic goal

  • Hypoxically stored RBCs restored mean arterial pressure (MAP) and vascular resistance compared to conventionally stored RBCs


“When we look at all of the data from our study, it appears that storing RBCs hypoxically could result in better transfusion patient outcomes,” said Principal Investigator Pedro Cabrales, PhD, Professor of Bioengineering, University of California, San Diego. “The potential to deliver a higher-quality red blood cell that improves patient recovery and expands the blood supply by reducing the number of transfused units will have a significant impact in those patients suffering from hemorrhagic shock.”

The researchers addressed the need for clinical trials to determine the safety and efficacy of hypoxically stored RBC transfusions in trauma patients with hemorrhagic shock. Hemanext is committed to supporting this ongoing research.

“This study, performed under the expert guidance of Dr. Pedro Cabrales, serves as an important milestone in our development program for hypoxically stored RBCs. We are delighted with the results and will continue to pursue our goal of bringing this new technology to patients everywhere,” said Hemanext President and CEO Martin Cannon.

Click here to access an abstract of the study.

ABOUT HEMANEXT

Hemanext is a privately held medical technology company dedicated to improving the quality, safety, efficacy and cost of transfusion therapy. The company’s research and development efforts center on the study and future commercialization of hypoxically stored red blood cells (RBCs). HEMANEXT ONE®, our initial product offering, is designed to improve the quality of life for chronic and high-volume transfusion patients while reducing costs.

Visit Hemanext.com to learn more.

Share article on social media or email:

Industry: Healthcare

PAINWeekEnd in Charleston, South Carolina, Offers CE/CME Education to Address the Opioid Abuse Public Health Crisis

Leave a comment


News Image

As more and more of the fog is lifted from the opioid crisis that we face as a nation, it is extremely important for healthcare professionals to stay abreast of best practices in pain management…


MONTCLAIR, N.J. (PRWEB)

PAINWeekEnd on November 16 at the Charleston Marriott, 170 Lockwood Blvd., in South Carolina, will be an educational and exciting program providing busy clinicians and allied healthcare practitioners with 6.0 hours of relevant, practical instruction in the management of chronic pain.

Charleston County, South Carolina, had the 3rd highest amount of pain medications dispensed in the entire country from 2006 to 2012. During that span, South Carolina dispensed almost 2 billion opioid pills. Where do healthcare professionals even begin to attempt to improve patient care, and ultimately save lives? At PAINWeekEnd, faculty member Mark Garofoli, PharmD, MBA, BCGP, CPE, will present Pain Management at Ground Zero. He states, “As more and more of the fog is lifted from the opioid crisis that we face as a nation, it is extremely important for healthcare professionals to stay abreast of best practices in pain management in order to prevent the countless speedbumps (such as limited time and patient mindsets) from swaying one away from improving patient care. I look forward to helping PAINWeekEnd attendees wrap their minds around the vast amount of information, and misinformation, within not only the ‘opioid crisis’ but the War on Drugs overall as we know it, or think we know it.” Dr. Garofoli will also present Thug Drugs, a rapid-fire review of dozens of common substances of abuse.

Other course topics to be offered at PAINWeekEnd Charleston include The Gang that Couldn’t Shoot Straight: Reconsidering the CDC Guideline; Diabetic Peripheral Neuropathic Pain: Evaluating Treatment Options; Migraines and More; and Osteoarthritis Pain: Past, Present, and Future.

Commercially supported activities—addressing a range of product, disease state, and medical information topics—will also be presented.

For more information about this or other regional conferences, and to register for $129, go to the PAINWeekEnd website. BONUS: PAINWeekEnd registrants may register for the 2020 PAINWeek National Conference, September 8-12, in Las Vegas, for $200 off the regular online published price.

PAINWeekEnd is provided by Global Education Group. About Global Education Group:

Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.

Share article on social media or email:

Health: Psychology

Psychedelic Feminism Champions Cultural Evolution in the Age of Extinction

Leave a comment


Brazilian Amazon

Cosmic Sister Emerging Voices Award recipient Alice Fortes on location in the Brazilian Amazon. Photo by Camilla Coutinho.

“Our species is responsible for this age of extinction. A true balance of power across the gender spectrum—globally—is the only way humans (and non-humans) will survive.” – Zoe Helene


AMHERST, Mass. (PRWEB)

This November, the environmental feminist group Cosmic Sister is sponsoring female thought leaders and emerging voices to represent the medicine at Spirit Plant Medicine Conference, November 1 – 3 on the University of British Columbia’s Vancouver campus, located on the traditional, ancestral, and unceded territory of the Squamish, Musqueam and Tsleil-Waututh First Nations.

Cosmic Sister’s Psychedelic Feminism champions women’s empowerment and frontline voices, emphasizing our responsibility—as Earth’s apex predator—to evolve ethically and our natural right to journey with sacred plant (and fungi) such as ayahuasca, cannabis, peyote, iboga and psilocybin mushrooms as a way to jump-start rapid cultural evolution, starting with women.

“Our species is responsible for this age of extinction. A true balance of power across the gender spectrum—globally—is the only way humans (and non-humans) will survive,” said Cosmic Sister founder Zoe Helene, who coined the term Psychedelic Feminism, which she describes as “a realistic, practical, yet hopeful approach to a much-needed shift of global consciousness.”

Cosmic Sister offers an interconnected quartet of merit-based Psychedelic Feminism educational advocacy grants—Women of the Psychedelic Renaissance, Cosmic Sisters of Cannabis and the original, immersive Plant Spirit Grant—to support women’s voices in psychedelics (and cannabis) culture. The new Emerging Voices Award, launched last month in partnership with the Sleeping Octopus Assembly on Psychedelics (SOAP) in Pittsburgh, PA, helps individuals who demonstrate potential in the field of psychedelics strengthen their visibility in the community. Cosmic Sister will also partner with other reputable events and the Spirit Plant Medicine Conference for this award.

Recipients from Canada and the United States share a passion for human and non-human rights and environmental protection and credit psychedelics for changing the course of their lives for the better. Inspired and action-oriented, they remain hopeful amidst the chaos of challenging times. “National borders and territorial boundaries have nothing to do with the natural world,” says Helene.

WOMEN OF THE PSYCHEDELIC RENAISSANCE GRANTS

The following women received Cosmic Sister Women of The Psychedelic Renaissance grants to speak at Spirit Plant Medicine Conference.

Cannabis and hemp activist and cultivator Rachael Carlevale (@Ganjasana) will present “Integration: Building Bridges to Cannabis Spirit with Nature as Our Ally;” Indigenous activist and cannabis ambassador Antoinette Cruz (@dabzilla_antoinette) will present “Decolonization of A Nation: Spirit, Plant Medicine From An Indigenous Perspective;” hashish consultant, writer, educator and media personality The Dank Duchess (@TheDankDuchess) will present “Getting Lit: Spiritual Ascension through Collective Ecstasy;” and master herbalist, psychedelic elder, author and educator Brigitte Mars (@brigitte.mars) will present “Just Say How? Preparation for an Epic Psychedelic Experience.”

Zoe Helene (@CosmicSister), an artist, environmentalist and cultural activist, will present “Psychedelic Feminism—It’s Not All About Us (Humans).” She will not be live-streamed or recorded. “I want to share with those who are present,” she says, “as we would in a sacred space such as a temeno, tipi or maloca. The magic is in the living moment.”

COSMIC SISTER EMERGING VOICES AWARD

The new Cosmic Sister Emerging Voices Award (CS EVA) acknowledges women who work tirelessly in supportive, behind-the-scenes roles, as well as talented newcomers who shine in spotlight positions. “These are women to watch,” Helene says.

In partnership with Spirit Plant Medicine Conference, the following women received a Cosmic Sister Emerging Voices Award, which includes a complimentary ticket to attend SPMC, on-campus accommodations (for recipients traveling from the United States) and an invitation to participate in an intimate, multi-cultural, women-only pre-conference gathering on October 31. “In many ancient spiritual traditions, this is a sacred night when the veil between the worlds is lifted and ancestors feel more present, a night to celebrate the death of the old, clearing space for rebirth,” Helene explains. “The timing feels perfectly apropos.”

Recipients include interdisciplinary artist and storyteller Tonye Aganaba (@tonyeaganaba); community organizer, cannabis yogi and facilitator Celina Archambault (@plant_tigress); social worker and community organizer Anne-Marie Armour; hemp advocate and cannabis entrepreneur and women’s basketball coach Laura Beohner (@TheHealingRose); community diviner and Renaissance woman Mia Cara Cosco (@miacosco); Brazilian photographer, environmentalist and ayahuasca researcher Alice Fortes (@alicecfortes); psychiatric nurse and martial artist Taylor Hayes (@psy.nurse); plant food alchemist and chef and yoga instructor Sarinda Hoilett (@Sarinah); strategist, communicator, connector and social alchemist Andrea Langlois (@andreamlanglois); ethical personal care and natural products independent consultant Caitlin Moakley (@soilandspirit); scientist and pollinator advocate Dawn Musil (@dawn_musil); urban gardener and community artist Sabrina Pilet-Jones (@sabrinas_garden); PhD student, shamanism researcher, and plant-lover Laurel Sugden (@laurel.sugden); performing artist and adventurer Vanessa Yuen (@van_lefan).

For full biographies and photos, please visit Psychedelic Feminism Grant Recipients.

WOMEN OF COLOR IN PSYCHEDELICS

Women of color’s voices are greatly underrepresented in the psychedelic plant community, despite their demonstrated talent for, connection to, and keen interest in these profound medicines. Cosmic Sister is proud to sponsor the panel discussion “Rising Voices: Women of Color in the Sacred Plant Community,” on the main stage. Women of the Psychedelic Renaissance grant recipient and main stage speaker The Dank Duchess will moderate the panel, which includes Cosmic Sister Emerging Voices recipients Tonye Aganaba, Sarinda Hoilett, Sabrina Pilet-Jones and Vanessa Yuen.

MILESTONE YEAR

All speaking grants were covered by donations. Cosmic Sister depends on community support, mostly from individuals. Last month, Women’s Sacred Medicine Alliance, a new group of Canadian psychedelic feminists, hosted the Psychedelic Symposium & Cosmic Sister Fundraiser in Vancouver, BC, featuring local medicine women and a silent auction that included several cruelty-free feather smudge fans by local artist Mari Hashimoto of Trillium Healing Path.

Several sizable donations were made by men. Cosmic Sister’s psychedelic feminism educational advocacy projects are supported in part by influential males in the field, including mycologist and medical researcher Paul Stamets; executive director of Divination Foundation Paulo Obrien, ethnobotanist and medicine hunter Chris Kilham; Spirit Plant Medicine Conference co-organizer Stephen Gray; founder and executive director of Multidisciplinary Association for Psychedelic Studies (MAPS) Rick Doblin, Cosmic Sister’s educational advocacy fiscal sponsor; and executive director of MAPS Canada Mark Haden.

“We love and appreciate our male allies,” Helene says, “These men understand that we’re in relationship with each other on the same vulnerable planet and that action is character.”

“We are riding the wave of a revolution in consciousness, a quantum leap in intelligence,” says mycologist and medical researcher Paul Stamets, “If we can harness and use these substances responsibly, we won’t fail to create the paradigm shift so critical for our collective survival. Women’s voices are fundamental to the conversation.”

Kilham, Helene’s husband and partner and founder of Medicine Hunter, a primary Cosmic Sister sponsor, agrees. “These women are not the voices of tomorrow,” he says, “They are the voices of today.”

“As the temple of wisdom is being re-opened,” says Gray, “this emergence is essential for the rebalancing of the feminine and masculine principles and the healing of the Earth and all her inhabitants.”

“We all need to be on the psychedelic healing bus for this movement to be in balance,” says Haden. “No one gets left behind in our collective quest to heal and to offer healing to individuals, couples, communities and our planet as a whole. Equal representation and cooperation at all levels of the psychedelic renaissance is a must.”

These educational grants would not be possible without community support. Cosmic Sister deeply appreciates tax-deductible donations by way of its fiscal sponsorship with the Multidisciplinary Association for Psychedelic Studies (MAPS). All contributions made through this form will be allocated to Cosmic Sister’s educational advocacy initiatives, minus modest administrative processing fees.

ABOUT COSMIC SISTER

Cosmic Sister (@CosmicSister) is an environmental feminist collective that connects kindred-spirit trailblazing women who understand that true balance of power across the gender spectrum—globally—as the only way humans (and non-humans) will survive. Cosmic Sister’s psychedelic feminism educational advocacy initiatives promote safe, legal, intentional journeying with sacred plants and fungi as a way for women to explore the wilderness within, where they can discover fresh, liberating perspectives on core women’s rights issues. Contact: media@cosmicsister.com. Connect: @CosmicSister

Cosmic Sister’s immersive Plant Spirit Grant program is funded internally. Cosmic Sister’s Emerging Voices Educational Award program is funded in part by participating partners such as the Spirit Plant Medicine Conference.

Donations for Cosmic Sister’s educational advocacy initiatives are fully tax-deductible through Cosmic Sister’s fiscal sponsor, the Multidisciplinary Association for Psychedelic Studies (MAPS). All donations go directly to educational advocacy and are greatly appreciated. To donate, please visit Support Cosmic Sister. #CosmicSister #PsychedelicFeminism #ZoeHelene #Psychedelics #Psychedelic #Earth #ClimateChange #Amazon #Rainforest #Brazil #Peru

For biographies and photos of grant recipients and more information on these projects, visit Psychedelic Feminism.

ABOUT THE LEAD IMAGE

In the Nova Esperança (“New Hope”) village in the Gregório River Indigenous Territory of the Brazilian Amazon, an indigenous Yawanawá woman applies protective jenipapo butterfly markings, using juice from the jenipapo fruit, on Alice Fortes in preparation for medicine work with uni, the Yawanawá name for ayahuasca, in the deep rainforest.

Alice Fortes, a recipient of Cosmic Sister’s Emerging Voices Award, is an environmentalist, photographer, ayahuasca researcher and graduate student studying under the mentorship of anthropologist Wade Davis at the University of British Columbia in Vancouver. She was nominated by her classmate Laurel Sugden, also a Cosmic Sister Emerging Voices Award recipient.

Photo by Camilla Coutinho (@camillacoutinhosilva).

ABOUT MULTIDISCIPLINARY ASSOCIATION FOR PSYCHEDELIC STUDIES (MAPS)

Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) nonprofit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. For more information, please contact Brad Burge, director of communications and marketing, brad@maps.org Connect: @MAPSnews

ABOUT SPIRIT PLANT MEDICINE CONFERENCE

The intention of Spirit Plant Medicine Conference is to offer accurate, respectful, and most of all beneficial information and inspiration on the use of and larger context around sacred healing plants. Now in its 9th year, the mission of the SPMC is to help guide this work forward by bringing a world-class international group of leading visionary voices to Vancouver. SpiritPlantMedicine.com

ABOUT MEDICINE HUNTER

Founded by medicine hunter, author, and educator Chris Kilham, the three-fold purpose of Medicine Hunter is to promote natural, plant-based medicines, to protect the natural environment, and to support indigenous cultures. MedicineHunter.com Connect: @MedicineHunter

Health

The National Safety Council Creates Opioids at Work Toolkit to Help Employers Reduce the Impact of Opioids in the Workplace

Leave a comment


OSHA Training Institute Education Center Logo

OSHA Training Institute Education Center

The Opioids at Work Employer Toolkit is designed to help employers understand how opioids impact the workplace, recognize signs of impairment, educate employees on the risks of opioid use, develop drug-related HR policies and support employees who are struggling with opioid misuse.


DUBLIN, Calif. (PRWEB)

The OSHA Training Institute Education Center at Chabot-Las Positas Community College District, the only OSHA authorized OTI Education Center headquartered in Northern California, is highlighting the National Safety Council’s Opioids at Work Employer Toolkit to help employers address the impact of the opioid epidemic in their workplaces. The employer toolkit features sample policies, fact sheets, presentations, safety talks, posters, white papers, reports, videos and more, to guide employers in the implementation of workplace opioids programs.

“Employers across the US are being impacted by the opioid epidemic, and many are working to help reduce the negative effects of opioid abuse in their workplaces,” says Cari Elofson-Callahan, Assistant Director of the OSHA Training Institute Education Center at Chabot-Las Positas Community College District. “The Opioids at Work Employer Toolkit is designed to help employers understand how opioids impact the workplace, recognize signs of impairment, educate employees on the risks of opioid use, develop drug-related HR policies and support employees who are struggling with opioid misuse.”

The Opioids at Work Employer Toolkit is organized into several key subject matter areas, including the Basics, Human Resources, Safety Professionals, Supervisors, Employee Education and Other Resources. Each subject matter area features links to a variety of topics. For example, topics under the Basics include Opioids in the Workplace, Understanding Treatment and Recovery, How Opioids Impact Employees’ Safety and Your Bottom Line, Month-by-Month Implementation Plan and Building a Recovery-Friendly Workplace.

The structure of the Opioids at Work Employer Toolkit allows employers to address specific relevant topics or develop a comprehensive program, depending on the needs and internal capacity of each organization. Regardless of approach, the National Safety Council strongly recommends that the entire organization, including management, marketing and communications, human resources, environmental health and safety, legal and frontline workers, is represented from the onset to ensure buy-in and enhance the effectiveness of the program.

Visit the National Safety Council’s Opioids at Work Employer Toolkit website to access additional information, extensive materials and other employer resources.

About the OSHA Training Institute Education Center

The OSHA Training Institute Education Center at Chabot-Las Positas Community College District offers high quality Occupational Safety & Health Administration (OSHA) standards-based training for construction, maritime and general industries in Dublin, California, conveniently located in the San Francisco Bay Area, as well as twelve additional locations throughout California, Nevada and Hawaii. Programs offered include OSHA safety standards, Outreach Trainer courses, Cal/OSHA standards and customized on-site safety training. For more information, including a complete course schedule, visit the OSHA Training Institute Education Center website, email otc@clpccd.org or call (866) 936-OSHA (6742).

Share article on social media or email:

Health

R3 Stem Cell Now Teaching PRP Facelift at Its Regenerative Aesthetics Training Course

Leave a comment


https://www.prweb.com/

Stem Cell and PRP Facelift Training

These procedures are the future of aesthetics. PRP therapy in conjunction with stem cells and exosomes work exceptionally well with thread lifting for optimal outcomes. But they’re hard to do, so hands on training is critical!


SCOTTSDALE, Ariz. (PRWEB)

R3 Stem Cell is now including the PRP facelift procedure at its regenerative aesthetics training course November 15-16, 2019 in Scottsdale, AZ. The aesthetics training is hands on with real patients, real stem cell biologics, and expert trainers to walk providers through the techniques.

Most aesthetics courses include few models and minimal hands on training. R3 Stem Cell Training understands that facial rejuvenation procedures are best learned with repetition on real patients under expert trainer supervision. Only real biologics are used, including PRP, stem cell and exosomes along with PDO thread lifts.

In conjunction with stem cell and exosome therapy, facial rejuvenation is a highly effective procedure where hands on training is exceptionally helpful. Real patients are evaluated so providers can understand the decision making process for whether to incorporate fillers, thread lifts, micro needling or facial injections for the treatments. The biologics decision will also be taught, since it’s not a straightforward procedure.

PRP therapy, which is short for platelet rich plasma therapy, is not as straightforward as most providers think. At the R3 training, providers will learn the difference between a single versus double spin, when to use platelet poor versus rich plasma, and how to activate the biologic as well for the best outcome. In addition, the attendees will learn where to inject on the face, needle size, dilution ratios, how to numb appropriately and all about pricing.

Said R3 CEO David Greene, MD, MBA, “These procedures are the future of aesthetics. PRP therapy in conjunction with stem cells and exosomes work exceptionally well with thread lifting for optimal outcomes. But they’re hard to do, so hands on training is critical!”

The regenerative aesthetics and PRP Facelift training fills up fast, so providers interested should visit https://stemcelltrainingcourse.org/aesthetics or call (844) GET-STEM quickly.

Share article on social media or email:

Industry: Healthcare

Dr. Brock Pumphrey Offers LANAP and LAPIP Laser Procedures to Treat Gum Disease Around Teeth and Implants

Leave a comment


https://www.prweb.com/

Dr. Brock Pumphrey

With the LANAP and LAPIP protocols, we are able to address the very real and serious problem of gum disease while also keeping our patients comfortable due to their minimally invasive nature.


ATLANTA (PRWEB)

Dr. Brock Pumphrey of Atlanta Center for Advanced Periodontics, Cosmetic & Implant Dentistry is now certified in the LANAP and LAPIP protocols. Dr. Pumphrey is on the leading edge of periodontics, treating patients with a minimally invasive laser treatment with favorable and predictable results to save their teeth and implants and help regrow bone lost to periodontitis peri-implantitis.

“Our top priority is your dental health and smile, and part of that commitment includes incorporating state of the art technology and cutting edge techniques to provide the best results possible for our patients,” said Dr. Pumphrey. “With the LANAP and LAPIP protocols, we are able to address the very real and serious problem of gum disease while also keeping our patients comfortable due to their minimally invasive nature.”

The LANAP protocol can be performed in as little as one treatment session, and is safe to use on patients with health concerns such as diabetes, heart disease, and hemophilia, without discontinuing medication. It is the only scientifically proven laser gum disease treatment FDA cleared to regenerate the bone and tissues lost to gum disease.

The LAPIP protocol is a first line treatment approach for failing implants or peri-implantitis as it addresses the underlying causes affecting the health of both the bone and the gum tissue around the implant. A fiber the width of 3 human hairs is inserted between the implant and the gum. Laser energy kills bacteria, vaporizes cement, and stimulates stems cells found in your bone to reduce the bacterial infection and promote healing.

Gum disease is a chronic bacterial infection that rarely has any symptoms in its early stages. Despite the lack of symptoms or pain, the disease can still cause serious damage to your mouth, leading to loss of teeth, which has been tied to decreased lifespan. Additionally, several other serious illnesses like cancer, heart disease and diabetes have suggested links to gum disease.

For information on the LANAP and LAPIP gum disease treatments, call Atlanta Center for Advanced Periodontics, Cosmetic & Implant Dentistry at (404) 982-4797 for an appointment.

About Dr. Pumphrey

Dr. Brock James Pumphrey attended Holy Innocents Academy and graduated from Woodward Academy in 2002. Dr. Pumphrey graduated from Florida State University in 2006. After college, he worked in the cardiac rhythm management field in places like Tampa Bay, Florida and Greenville, South Carolina. After a couple of successful years Dr. Pumphrey decided to pursue his passion and dream of becoming a Periodontist. He attended Augusta University (previously known as Medical College of Georgia) where he earned his dental degree, then continued his education at Augusta University in advanced periodontics for an additional 3 years earning his certificate. Dr. Pumphrey is also one of the few Periodontists in the Atlanta area Board Certified in Periodontology and Dental Implant Surgery.

After school, Dr. Pumphrey worked in the Buckhead area for over a year before pursuing interest in the Midtown area with Dr. Shuster. Dr. Shuster gave Dr. Pumphrey a great opportunity to grow and spread his knowledge and practice philosophy.

Dr. Pumphrey is the leader of two Frank Spear Study clubs here in Atlanta, an active member of Hinman Dental Society, Georgia Dental Association, American Academy of Periodontology, Academy of Osseointegration and The American Dental Association. He loves Periodontics for its focus on interdisciplinary treatment planning, soft tissue management, implant dentistry, accelerate orthodontics, IV sedation, Chao pinhole technique, esthetics and so much more.

Dr. Pumphrey and his wife Cristina met in Tallahassee, Florida in college and were married in 2011. They currently have two children, Brock, Jr. and Pierce. Dr. Pumphrey loves both professional and collegiate athletics here in the city of Atlanta and Florida State. He enjoys time with his family, fishing, golf, Crossfit and tennis.

Share article on social media or email:

Health

Element AI to Attend 2019 ISPE Annual Meeting & Expo—’Operationalizing AI’ for Pharmaceutical Engineering

Leave a comment


https://www.prweb.com/

Element AI at ISPE 2019 Las Vegas Booth L-1 Lobby

Element AI will showcase its Advisory, Enablement, and AI-powered product expertise in manufacturing and supply chain at ISPE 2019 Annual Meeting & Expo


LAS VEGAS (PRWEB)

Element AI, a global developer of artificial intelligence-powered (AI) services and software solutions, today announced it is attending the 2019 International Society for Pharmaceutical Engineering (ISPE) Annual Meeting & Expo in Las Vegas October 27-30.

Element AI will meet with pharmaceutical and biopharmaceutical business partners to showcase how it is ‘operationalizing AI’ to help pharma-manufacturing industry integrate AI and machine learning (ML) solutions from ‘lab to impact’ with its mix of Advisory and Enablement services and supply chain and manufacturing products. The company will also provide an overview of its ‘AI Maturity Framework’ to help organizations assess their capabilities to benefit from AI and ML business transformation.

At the Expo, the company will showcase its product, Element AI Knowledge Scout. Created to enable decision-making, Knowledge Scout is an intuitive search application that gives manufacturing specialists the information they need to rapidly evaluate and resolve critical situations. This product facilitates access to information and the sharing of tacit knowledge within an organization.

Element AI will present an overview session of Knowledge Scout on the Discovery Stage in the Expo Hall at Caesars Palace on Tuesday, October 29th, at 12:20pm pacific time.

Visit Element AI at booth #L1 at Caesars Palace to meet with Element AI employees, see their AI-powered manufacturing and supply chain products and learn about the company’s AI Advisory and Enablement services.

For more information about Element AI and its AI-powered product line, visit: https://www.elementai.com/products

To learn about Element AI Advisory and Enablement Services, visit: https://www.elementai.com/products/advisory-and-enablement

SHOW ATTENDEES and PRESS: To schedule an onsite business meeting or media interview to learn more about Element AI, contact: Jorielle.Nunag@FHhighroad.com.

                                                         ###

About Element AI            

Element AI develops AI-enabled products, services, and tools that help enterprises ‘operationalize AI’ to work smarter, together. Founded in 2016 by seasoned entrepreneur JF Gagné and pioneering AI researcher and A.M. Turing Award recipient, Yoshua Bengio, the company turns cutting-edge research and industry expertise into software solutions that continuously learn and improve. Focusing primarily on manufacturing, supply chain, and financial services and sectors, Element AI provides end-to-end AI integration guidance throughout its customers’ AI journey—from advisory and enablement, to integration, deployment and support. The company has nearly 500 employees, including more than 100 PhDs, working in five cities across North America, Europe, and Asia. Element AI maintains a strong connection to academia with an open, collaborative approach to research, and takes a leadership position in policy-making around the impact of AI on society, and AI for Good initiatives. For more information, visit: https://www.elementai.com.

Share article on social media or email:

Industry: Healthcare

Advocate Health Care is enrolling adults with Down syndrome for the first research study in the Down Syndrome Clinical Trials Network Supported by LuMind IDSC Foundation

Leave a comment


Photo of Karen Gaffney and Ryan Hartman

Karen Gaffney, Down syndrome research advocate, and Ryan Hartman, LuMind IDSC Foundation Board of Directors. Photo provided by LuMind IDSC Foundation.

“In spite of recent advances in medical care, adults with Down syndrome continue to face very significant challenges, including a markedly increased risk of Alzheimer disease. We hope that this work will lead to better treatments for older people with Down syndrome,” said Brian Chicoine, MD


PARK RIDGE, Ill. (PRWEB)

On the Advocate Lutheran General Hospital campus, Park Ridge, Illinois, Advocate Medical Group Adult Down Syndrome Center researchers are enrolling adults with Down Syndrome who are older than 25 in the Longitudinal Investigation for Enhancing Down Syndrome Research Study (LIFE-DSR). The goal of the study is to better understand the health issues people with Down syndrome face as they age, particularly their risk for Alzheimer’s disease and dementia.

“In spite of recent advances in medical care, adults with Down syndrome continue to face very significant challenges, including a markedly increased risk of Alzheimer disease,” said Brian Chicoine, MD, site principal investigator for Advocate Health Care and cofounder and medical director for the Advocate Medical Group Adult Down Syndrome Center. “We are excited to be participating in the LIFE-DSR study and hope that this work will lead to better treatments for older people with Down syndrome.”

Diagnosing Alzheimer’s is complex, particularly in people with Down syndrome. With no single test currently available, diagnosis is based on an individual’s history, physical examination and cognitive testing. The LIFE-DSR study will observe adults with Down syndrome to validate tests of cognition and function designed specifically for adults with Down syndrome. The clinical trials network will also collect blood samples from all study participants to aid in the development of blood tests for Alzheimer disease.

The clinical trials network is sponsored by Alana Foundation and biopharmaceutical companies, AC Immune and Lundbeck with $3 million in initial funding. LuMind IDSC Foundation directs the clinical trials network. Through a research grant, Advocate received more than $300,000 from LuMind IDSC to participate as the first clinical trial site in Illinois.

“We believe that the clinical trials network will open up greater access to clinical research for people with Down syndrome and that is why LuMind IDSC is excited to be providing funding and leadership for the first study in the network, the LIFE-DSR study,” said Hampus Hillerstrom, LuMind IDSC chief executive officer.

Researchers will enroll more than 270 adults with Down Syndrome older than 25 in the LIFE-DSR study nationwide and follow them for two years. Eligible study subjects must have a study partner, and both must provide consent to participate. Participants who enroll through Advocate Health Care will be compensated $50 for each completed visit (three total) and reimbursed for up to $50 for travel costs for visits.

“We’re pleased to collaborate on this innovative trial designed for patients with Down syndrome,” said Katie Wozniak, director of specialty research for Advocate Research Institute. “It is a privilege to serve this important community and to partner in efforts that may advance their future care and diagnostic testing.”

To learn more about the LIFE DSR Study, contact Monika Kapinos at 847-723-2243 or LGH-LIFE-DSR@advocatehealth.com.

Share article on social media or email: